{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:03:34Z","timestamp":1791644614665,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s12325-008-0096-9","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T06:20:49Z","timestamp":1220941249000},"page":"858-870","source":"Crossref","is-referenced-by-count":85,"title":["Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis"],"prefix":"10.1007","volume":"25","author":[{"given":"Jodi","family":"Luchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,9]]},"reference":[{"key":"96_CR1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3129\/i08-016","volume":"43","author":"W.B. Jackson","year":"2008","unstructured":"Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol. 2008;43:170\u2013179.","journal-title":"Can J Ophthalmol"},{"key":"96_CR2","first-page":"200","volume":"21","author":"R.E. Smith","year":"1995","unstructured":"Smith RE, Flowers CW Jr. Chronic blepharitis: a review. CLAO J. 1995;21:200\u2013207.","journal-title":"CLAO J"},{"key":"96_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1542-0124(12)70139-8","volume":"1","author":"G.N. Foulks","year":"2003","unstructured":"Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003;1:107\u2013126.","journal-title":"Ocul Surf"},{"key":"96_CR4","first-page":"314","volume":"105","author":"J.P. McCulley","year":"1986","unstructured":"McCulley JP, Dougherty JM. Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc U K. 1986;105:314\u2013318.","journal-title":"Trans Ophthalmol Soc U K"},{"key":"96_CR5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/bjo.68.8.524","volume":"68","author":"J.M. Dougherty","year":"1984","unstructured":"Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol. 1984;68:524\u2013528.","journal-title":"Br J Ophthalmol"},{"key":"96_CR6","first-page":"486","volume":"27","author":"J.M. Dougherty","year":"1986","unstructured":"Dougherty JM, McCulley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:486\u2013491.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"96_CR7","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0161-6420(90)32361-8","volume":"97","author":"D. Seal","year":"1990","unstructured":"Seal D, Ficker L, Ramakrishnan M, Wright P. Role of staphylococcal toxin production in blepharitis. Ophthalmology. 1990;97:1684\u20131688.","journal-title":"Ophthalmology"},{"key":"96_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archopht.1987.01060030129042","volume":"105","author":"B.J. Mondino","year":"1987","unstructured":"Mondino BJ, Caster AI, Dethlefs B. A rabbit model of staphylococcal blepharitis. Arch Ophthalmol. 1987;105:409\u2013412.","journal-title":"Arch Ophthalmol"},{"key":"96_CR9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9394(14)72383-9","volume":"111","author":"L. Ficker","year":"1991","unstructured":"Ficker L, Ramakrishnan M, Seal D, Wright P. Role of cell-mediated immunity to staphylococci in blepharitis. Am J Ophthalmol. 1991;111:473\u2013479.","journal-title":"Am J Ophthalmol"},{"key":"96_CR10","volume-title":"Ocular Pathology","author":"M. Yanoff","year":"1989","unstructured":"Yanoff M, Fine B. Ocular Pathology. Philadelphia, PA: J. B. Lippincott; 1989."},{"key":"96_CR11","first-page":"3","volume":"1","author":"M.H. Friedlaender","year":"2007","unstructured":"Friedlaender MH, Protzko E. Clinical development of 1% azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy. Clin Ophthalmol. 2007;1:3\u201310.","journal-title":"Clin Ophthalmol"},{"key":"96_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","volume":"55","author":"G.W. Amsden","year":"2005","unstructured":"Amsden GW. Anti-inflammatory effects of macrolides\u2014an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother. 2005;55:10\u201321.","journal-title":"J Antimicrob Chemother"},{"key":"96_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2007.08.001","volume":"31","author":"E.J. Giamarellos-Bourboulis","year":"2008","unstructured":"Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int J Antimicrob Agents. 2008;31:12\u201320.","journal-title":"Int J Antimicrob Agents"},{"key":"96_CR14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(02)02042-3","volume":"450","author":"O. Culic","year":"2002","unstructured":"Culic O, Erakovic V, Cepelak I, et al. Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur J Pharmacol. 2002;450:277\u2013289.","journal-title":"Eur J Pharmacol"},{"key":"96_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9394(82)90197-0","volume":"94","author":"F.L. Ferris 3rd","year":"1982","unstructured":"Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91\u201396.","journal-title":"Am J Ophthalmol"},{"key":"96_CR16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0161-6420(13)38009-9","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group.","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 1991;98:741\u2013756.","journal-title":"Ophthalmology"},{"key":"96_CR17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","volume":"27","author":"K. Smith","year":"2005","unstructured":"Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther. 2005;27:1329\u20131342.","journal-title":"Clin Ther"},{"key":"96_CR18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00003226-199110010-00010","volume":"10","author":"L.R. Groden","year":"1991","unstructured":"Groden LR, Murphy B, Rodnite J, Genvert GI. Lid flora in blepharitis. Cornea. 1991;10:50\u201353.","journal-title":"Cornea"},{"key":"96_CR19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/bjo.69.8.604","volume":"69","author":"D.V. Seal","year":"1985","unstructured":"Seal DV, McGill JI, Jacobs P, Liakos GM, Goulding NJ. Microbial and immunological investigations of chronic non-ulcerative blepharitis and meibomianitis. Br J Ophthalmol. 1985;69:604\u2013611.","journal-title":"Br J Ophthalmol"},{"key":"96_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1542-0124(12)70150-7","volume":"2","author":"A.J. Bron","year":"2004","unstructured":"Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf. 2004;2:149\u2013165.","journal-title":"Ocul Surf"},{"key":"96_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0014-4835(03)00203-3","volume":"78","author":"J.P. McCulley","year":"2004","unstructured":"McCulley JP, Shine WE. The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res. 2004;78:361\u2013365.","journal-title":"Exp Eye Res"},{"key":"96_CR22","first-page":"2867","volume":"42","author":"P.I. Song","year":"2001","unstructured":"Song PI, Abraham TA, Park Y, et al. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Invest Ophthalmol Vis Sci. 2001;42:2867\u20132877.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"96_CR23","first-page":"2970","volume":"32","author":"J.M. Dougherty","year":"1991","unstructured":"Dougherty JM, McCulley JP, Silvany RE, Meyer DR. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci. 1991;32:2970\u20132975.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"96_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","volume":"26","author":"K.C. Yoon","year":"2007","unstructured":"Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factoralpha levels in tears of patients with dry eye syndrome. Cornea. 2007;26:431\u2013437.","journal-title":"Cornea"},{"key":"96_CR25","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(97)30014-1","volume":"104","author":"K. Barton","year":"1997","unstructured":"Barton K, Monroy DC, Nava A, Pflugfelder SC. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology. 1997;104:1868\u20131874.","journal-title":"Ophthalmology"},{"key":"96_CR26","first-page":"2283","volume":"42","author":"A. Solomon","year":"2001","unstructured":"Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283\u20132292.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"96_CR27","first-page":"2506","volume":"40","author":"A.A. Afonso","year":"1999","unstructured":"Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999;40:2506\u20132512.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"96_CR28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ico.0000176611.88579.0a","volume":"25","author":"H.D. Perry","year":"2006","unstructured":"Perry HD, Doshi-Carnevale S, Donnenfeld ED, Solomon R, Biser SA, Bloom AH. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea. 2006;25:171\u2013175.","journal-title":"Cornea"},{"key":"96_CR29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jop.2006.22.47","volume":"22","author":"M. Rubin","year":"2006","unstructured":"Rubin M, Rao SN. Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis. J Ocul Pharmacol Ther. 2006;22:47\u201353.","journal-title":"J Ocul Pharmacol Ther"},{"key":"96_CR30","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","volume":"118","author":"K.S. Kunert","year":"2000","unstructured":"Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol. 2000;118:1489\u20131496.","journal-title":"Arch Ophthalmol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0096-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-008-0096-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0096-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:55:52Z","timestamp":1559447752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-008-0096-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1007\/s12325-008-0096-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}